Cash Flow from Financial Activities: The net amount of cash transactions used in funding activities.
MediPharm Labs Corp. (T.LAB) had Cash Flow from Financial Activities of 66.70M for the most recently reported fiscal year, ending 2019-12-31.
| Income Statement Financials | |
-- |
|
1.24M |
|
-- |
|
-- |
|
-- |
|
5.23M |
|
-- |
|
5.09M |
|
5.09M |
|
0.85M |
|
0.85M |
|
0.85M |
|
0.85M |
|
5.23M |
|
7.14M |
|
120.00M |
|
134.63M |
|
0.01 |
|
0.01 |
|
| Balance Sheet Financials | |
-- |
|
-- |
|
-- |
|
127.24M |
|
-- |
|
-- |
|
-- |
|
28.34M |
|
98.90M |
|
98.90M |
|
98.90M |
|
131.53M |
|
| Cash Flow Statement Financials | |
-19.04M |
|
-24.53M |
|
|
Cash Flow from Financial Activities |
66.70M |
5.92M |
|
29.11M |
|
23.19M |
|
11.68M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.15 |
|
-- |
|
-- |
|
0.06 |
|
0.08 |
|
33.20% |
|
5.37% |
|
5.37% |
|
7.33% |
|
5.22% |
|
1.27% |
|
-43.49M |
|
-- |
|
-- |
|
-- |
|
0.77 |
|
1.68 |
|
4.69 |
|
77.77 |
|
0.86% |
|
0.86% |
|
0.67% |
|
0.81% |
|
1.00 |
|
-0.32 |
|
-0.14 |
|